drugset / Trial / NCT03503227

The Value of Prednisolone With Aspirin Before Embryo Transfer in Intracytoplasmic Sperm Injection (ICSI) Cycles

NCT03503227

Phase 2/3 Completed 250 enrolled Kasr El Aini Hospital
RandomizedParallel-groupSingle-blindOther

Summary

This study is a prospective, double-blind, randomized controlled trial . It includes 250 infertile patients scheduled for ICSI cycle. The patients will be randomly allocated into two equal groups; daily oral low dose Acetylsalicylic acid and group B patients will receive daily oral low dose Acetylsalicylic acid and Low dose prednisolone. All 250 participants undergo similar ICSI cycles. Primary outcome is clinical pregnancy rate per cycle. Secondary outcomes include number of oocytes retrieved, fertilization rate, number of embryos, embryo quality, chemical pregnancy rate, twins rate and miscarriage rate per cycle.

Timeline

Start
2018-04-23
Primary completion
2018-10-31
Completion
2018-10-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified 10 mg Oral
Comparator Aspirin Small molecule 75 mg Oral

Indications